ERIS Lifesciences consolidated net profit rises 31.23% in the September 2025 quarter
(14 Nov 2025)

Back
Net profit of ERIS Lifesciences rose 31.23% to Rs 120.19 crore in the quarter ended September 2025 as against Rs 91.59 crore during the previous quarter ended September 2024. Sales rose 6.93% to Rs 790.15 crore in the quarter ended September 2025 as against Rs 738.95 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales790.15738.95 7
OPM %36.4835.80 -
PBDT241.75209.59 15
PBT172.67129.11 34
NP120.1991.59 31

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew